Organisation paid for research Program year 2021 Source: CMS Open Payments

Compass Research North

Neither a doctor nor a teaching hospital

Research payments

$3,019,385

207 payments

Through program year 2021, Compass Research North is reported as receiving $3,019,385 in research payments, across 207 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$269,517	28
2020	Research	$1,263,781	98
2019	Research	$1,486,087	81

Breakdown

Who paid Research payments · program years 2019–2021

Genentech, Inc. $2,744,131 197 payments
F. Hoffmann-La Roche AG $275,253 10 payments

Studies the money was for Research payments · program years 2019–2021

Phase II Study of Anti Tau in Prodromal to Mild Ad $1,492,194 77 payments
Phase II Study for Moderate Ad $781,637 68 payments
PH Ib Crenezumab Eff Sfy Mild Mod Ad $275,253 10 payments
Gantenerumab Mild Ad $151,405 14 payments
SC Proof of Efficacy Study $132,464 11 payments
Prodromal to Mild Ad $126,568 16 payments
Gtp1 Phase I Longitudinal Study $47,864 9 payments
Gantenerumab Open Label Extension $12,000 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.